350 related articles for article (PubMed ID: 11653222)
1. Baboon-to-human transplants: should we proceed?
Arnold RM; Dresser R; Hefner P; Offner SK
Mak Rounds Health Faith Ethics; 1995 Oct; 1(3):1, 3-4, 8. PubMed ID: 11653222
[No Abstract] [Full Text] [Related]
2. AIDS test involving baboon is approved.
Altman LK
N Y Times Web; 1995 Jul; ():7. PubMed ID: 11647078
[No Abstract] [Full Text] [Related]
3. Cross-species transplants raise concerns about human safety.
Altman LK
N Y Times Web; 1996 Jan; ():11, 17. PubMed ID: 11646329
[No Abstract] [Full Text] [Related]
4. Considering experimentation and elusive truth: informed consent made difficult.
Brodeur D
Issues (St Louis Mo); 1992; 7(2):1-8. PubMed ID: 11659444
[No Abstract] [Full Text] [Related]
5. The changing clinical trials scene: the role of the IRB.
Mitchell SC; Steingrub J
IRB; 1988; 10(4):1-5. PubMed ID: 11650078
[No Abstract] [Full Text] [Related]
6. Are clinical trials of cell transplantation for Duchenne muscular dystrophy ethical?
Cho MK
IRB; 1994; 16(1-2):12-5. PubMed ID: 11652321
[No Abstract] [Full Text] [Related]
7. Transplant: urgent step or step off the edge?
Kolata G
N Y Times Web; 1996 Jan; ():16. PubMed ID: 11646330
[No Abstract] [Full Text] [Related]
8. FDA revises informed consent regulations for emergency research.
Menasché A; Levine RJ
IRB; 1995; 17(5-6):19-22. PubMed ID: 11653359
[No Abstract] [Full Text] [Related]
9. The regulation of fetal tissue transplantation: different legislative models for different purposes.
Hicks SC
Suffolk Univ Law Rev; 1993; 27(4):1613-29. PubMed ID: 11657050
[No Abstract] [Full Text] [Related]
10. The use of normal children as participants in research on therapy.
Gordon B; Prentice E; Reitemeier P
IRB; 1996; 18(3):5-8. PubMed ID: 11654409
[No Abstract] [Full Text] [Related]
11. When doctors and patients decide to test the far limits of treatment.
Altman LK
N Y Times Web; 1995 Dec; ():C3. PubMed ID: 11647096
[No Abstract] [Full Text] [Related]
12. Demarcating research and treatment interventions: a case illustration.
Goldberg JL; Phillips JO; Freedman B; Weijer C
IRB; 1992; 14(4):5-8. PubMed ID: 11651393
[No Abstract] [Full Text] [Related]
13. FDA's new rule on treatment use and sale of investigational new drugs.
Levine RJ
IRB; 1987; 9(4):1-4. PubMed ID: 11649946
[No Abstract] [Full Text] [Related]
14. This little piggy went to market: the xenotransplantation and xenozoonose debate.
Clark MA
J Law Med Ethics; 1999; 27(2):137-52. PubMed ID: 11657462
[No Abstract] [Full Text] [Related]
15. Is this a job for the IRB? The case of the ELISA assay.
Holder AR
IRB; 1985; 7(6):7-8. PubMed ID: 11649689
[No Abstract] [Full Text] [Related]
16. Proposal on waiver of informed consent poses major issues for research ethics.
Maloney DM
Hum Res Rep; 1997 Sep; 12(9):1-3. PubMed ID: 11660533
[No Abstract] [Full Text] [Related]
17. Institutional review board approval required by rule.
Maloney DM
Hum Res Rep; 1996 Aug; 11(8):3. PubMed ID: 11654440
[No Abstract] [Full Text] [Related]
18. Emergency trials 'by popular consent.
Kiernan V
New Sci; 1995 Nov; 148(2002):6. PubMed ID: 11656475
[No Abstract] [Full Text] [Related]
19. Shaking up the status quo: how AIDS activists have challenged drug development and approval procedures.
Dunbar MM
Food Drug Cosmet Law J; 1991 Sep; 46(5):673-706. PubMed ID: 11651380
[No Abstract] [Full Text] [Related]
20. IRB review of adverse events in investigational drug studies.
Prentice ED; Gordon B
IRB; 1997; 19(6):1-4. PubMed ID: 11656910
[No Abstract] [Full Text] [Related]
[Next] [New Search]
